drugset / Trial / NCT00158795

Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

NCT00158795 ↗

Phase 4 Completed 454 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

To assess safety and reactogenicity of GSK Biologicals' Haemophilus influenza type b vaccine co-administered with or without Chinese DTPw vaccine administered alone in healthy infants (3, 4 and 5 months of age)

Timeline

Start
2005-01
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Haemophilus Influenza type b vaccine Vaccine — —